Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HGEN

Humanigen (HGEN) Stock Price, News & Analysis

Humanigen logo

About Humanigen Stock (NASDAQ:HGEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.06 million shs
Average Volume
3.26 million shs
Market Capitalization
$24 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humanigen and its competitors with MarketBeat's FREE daily newsletter.

HGEN Stock News Headlines

Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline.
Humanigen, Inc. (HGEN)
0KB1.SG,0P00011RKD,0 (0KB1.SG)
Humanigen Inc (0KB2.BE)
Humanigen Inc HGENQ
See More Headlines

HGEN Stock Analysis - Frequently Asked Questions

Humanigen, Inc. (NASDAQ:HGEN) posted its quarterly earnings results on Friday, November, 12th. The company reported ($1.12) EPS for the quarter, missing analysts' consensus estimates of ($0.98) by $0.14. The company earned $1.04 million during the quarter, compared to analyst estimates of $0.40 million.

Shares of Humanigen reverse split before market open on Monday, September 14th 2020.The 1-5 reverse split was announced on Friday, September 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humanigen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Pfizer (PFE) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/12/2021
Today
8/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:HGEN
CIK
1293310
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.70 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.45) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
119,080,000
Free Float
93,240,000
Market Cap
$24 thousand
Optionable
No Data
Beta
-1.04

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:HGEN) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners